The MAP4K5 (mitogen-activated protein kinase kinase kinase kinase 5) antibody is a research tool used to detect and study the MAP4K5 protein, a member of the Ste20 family of serine/threonine kinases. MAP4K5 plays a critical role in cellular signaling pathways, particularly those regulating stress responses, apoptosis, and metabolic homeostasis. It activates downstream kinases, including JNK (c-Jun N-terminal kinase) and p38 MAPK pathways, influencing processes like inflammation, cell proliferation, and insulin signaling.
Antibodies targeting MAP4K5 are widely employed in techniques such as Western blotting, immunohistochemistry, and immunofluorescence to investigate its expression, localization, and interaction partners in various tissues and disease models. Research has linked MAP4K5 dysregulation to conditions such as cancer, neurodegenerative disorders, and metabolic syndromes, making it a potential therapeutic target.
These antibodies are typically validated for specificity and sensitivity using knockout controls or siRNA-mediated knockdown. Commercial MAP4K5 antibodies are available from multiple suppliers, often raised in hosts like rabbits or mice, with options targeting specific epitopes or post-translational modifications. Their applications span basic research to drug discovery, aiding in elucidating MAP4K5's role in cellular mechanisms and disease progression.